{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:16:01Z","timestamp":1790486161360,"version":"4.1.0"},"reference-count":74,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,11]]},"abstract":"<jats:sec><jats:title>Propose of review<\/jats:title><jats:p>Neuropsychiatric systemic lupus erythematosus (NPSLE) is an emerging frontier in lupus care encompassing a wide spectrum of clinical manifestations. Its pathogenesis remains poorly understood because of the complexity of pathophysiologic mechanisms involved and limited access to tissue. We highlight recent advances in the pathophysiology of neuropsychiatric lupus.<\/jats:p><\/jats:sec><jats:sec><jats:title>Recent findings<\/jats:title><jats:p>Disruption of blood\u2013brain barrier (BBB) facilitating entrance of neurotoxic antibodies into the central nervous system (CNS), neuroinflammation and cerebral ischemia are the key mechanisms. Disruption of the BBB may occur not only at the traditional BBB, but also at the blood\u2013cerebrospinal fluid barrier. Certain autoantibodies, such as anti-<jats:italic toggle=\"yes\">N<\/jats:italic>-methyl-<jats:sc>d<\/jats:sc>-aspartate receptors, antiribosomal P and antiphospholipid antibodies may cause injury in subsets of patients with diffuse neuropsychiatric disease. Activation of microglia via autoantibodies, interferon-a or other immune reactants, may amplify the inflammatory response and promote neuronal damage. New inflammatory pathways, such as TWEAK\/Fn14, Bruton's tyrosine kinase, Nogo-a and ACE may represent additional potential targets of therapy. Novel neuroimaging techniques suggest alterations in brain perfusion and metabolism, increased concentration of neurometabolites, indicative of glial activation, vasculopathy and neuronal impairment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Summary<\/jats:title><jats:p>NPSLE encompasses a diverse phenotype with distinct pathogenic mechanisms, which could be targeted by novel therapies or repositioning of existing drugs.<\/jats:p><\/jats:sec>","DOI":"10.1097\/bor.0000000000000655","type":"journal-article","created":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T11:33:02Z","timestamp":1565782382000},"page":"669-677","source":"Crossref","is-referenced-by-count":30,"title":["Update on the pathogenesis of central nervous system lupus"],"prefix":"10.1097","volume":"31","author":[{"given":"Dionysis","family":"Nikolopoulos","sequence":"first","affiliation":[{"name":"Laboratory of Immune Regulation and Tolerance, Autoimmunity and Inflammation, Biomedical Research Foundation of the Academy of Athens"},{"name":"Rheumatology and Clinical Immunology Unit, \u201cAttikon\u201d University Hospital, National and Kapodistrian University of Athens Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonis","family":"Fanouriakis","sequence":"additional","affiliation":[{"name":"Rheumatology and Clinical Immunology Unit, \u201cAttikon\u201d University Hospital, National and Kapodistrian University of Athens Medical School"},{"name":"Department of Rheumatology, \u2018Asklepieion\u2019 General Hospital, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios T.","family":"Boumpas","sequence":"additional","affiliation":[{"name":"Laboratory of Immune Regulation and Tolerance, Autoimmunity and Inflammation, Biomedical Research Foundation of the Academy of Athens"},{"name":"Rheumatology and Clinical Immunology Unit, \u201cAttikon\u201d University Hospital, National and Kapodistrian University of Athens Medical School"},{"name":"Department of Internal Medicine, Medical School, University of Cyprus, Nicosia, Cyprus"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230828","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrneurol.2014.148","article-title":"Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers","volume":"10","author":"Jeltsch-David","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"R2-20230828","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrrheum.2010.62","article-title":"Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations","volume":"6","author":"Bertsias","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"R3-20230828","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/BOR.0b013e328363eaf1","article-title":"Pathogenesis and treatment of CNS lupus","volume":"25","author":"Fanouriakis","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"R4-20230828","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1191\/0961203303lu501oa","article-title":"The blood-brain barrier in systemic lupus erythematosus","volume":"12","author":"Abbott","year":"2003","journal-title":"Lupus"},{"key":"R5-20230828","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12974-016-0537-3","article-title":"B cell and\/or autoantibody deficiency do not prevent neuropsychiatric disease in murine systemic lupus erythematosus","volume":"13","author":"Wen","year":"2016","journal-title":"J Neuroinflammation"},{"key":"R6-20230828","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.autrev.2016.07.009","article-title":"The role of B cells and autoantibodies in neuropsychiatric lupus","volume":"15","author":"Wen","year":"2016","journal-title":"Autoimmun Rev"},{"key":"R7-20230828","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nature22821","article-title":"Microglia-dependent synapse loss in type I interferon-mediated lupus","volume":"546","author":"Bialas","year":"2017","journal-title":"Nature"},{"key":"R8-20230828","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nrneurol.2015.143","article-title":"Type I interferon dysregulation and neurological disease","volume":"11","author":"McGlasson","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"R9-20230828","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jaut.2016.04.005","article-title":"Autoimmunity, neuroinflammation, pathogen load: a decisive crosstalk in neuropsychiatric SLE","volume":"74","author":"Jeltsch-David","year":"2016","journal-title":"J Autoimmun"},{"key":"R10-20230828","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/rheumatology\/kew341","article-title":"Brain histopathology in patients with systemic lupus erythematosus: identification of lesions associated with clinical neuropsychiatric lupus syndromes and the role of complement","volume":"56","author":"Cohen","year":"2017","journal-title":"Rheumatology"},{"key":"R11-20230828","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/rheumatology\/ker310","article-title":"Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients","volume":"51","author":"Govoni","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"R12-20230828","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/jnnp.58.5.548","article-title":"Oligoclonal banding of IgG in CSF, blood-brain barrier function, and MRI findings in patients with sarcoidosis, systemic lupus erythematosus, and Beh\u00e7et's disease involving the nervous system","volume":"58","author":"McLean","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R13-20230828","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","article-title":"2019 update of the EULAR recommendations for the management of systemic lupus erythematosus","volume":"78","author":"Fanouriakis","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"R14-20230828","doi-asserted-by":"crossref","first-page":"a020412","DOI":"10.1101\/cshperspect.a020412","article-title":"The blood-brain barrier","volume":"7","author":"Daneman","year":"2015","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"R15-20230828","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.autrev.2017.04.008","article-title":"The blood brain barrier and neuropsychiatric lupus: new perspectives in light of advances in understanding the neuroimmune interface","volume":"16","author":"Stock","year":"2017","journal-title":"Autoimmun Rev"},{"key":"R16-20230828","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jneuroim.2005.04.022","article-title":"Elevated immunoglobulin levels in the cerebrospinal fluid from lupus-prone mice","volume":"165","author":"Sidor","year":"2005","journal-title":"J Neuroimmunol"},{"key":"R17-20230828","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jaut.2018.03.001","article-title":"Mechanisms of neuropsychiatric lupus: the relative roles of the blood-cerebrospinal fluid barrier versus blood-brain barrier","volume":"91","author":"Gelb","year":"2018","journal-title":"J Autoimmun"},{"key":"R18-20230828","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3389\/fimmu.2018.00487","article-title":"A distinct T follicular helper cell subset infiltrates the brain in murine neuropsychiatric lupus","volume":"9","author":"Jain","year":"2018","journal-title":"Front Immunol"},{"key":"R19-20230828","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.neubiorev.2018.03.028","article-title":"Interaction between blood-brain barrier and glymphatic system in solute clearance","volume":"90","author":"Verheggen","year":"2018","journal-title":"Neurosci Biobehav Rev"},{"key":"R20-20230828","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3389\/fnins.2015.00075","article-title":"Outer brain barriers in rat and human development","volume":"9","author":"Br\u00f8chner","year":"2015","journal-title":"Front Neurosci"},{"key":"R21-20230828","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature14432","article-title":"Structural and functional features of central nervous system lymphatic vessels","volume":"523","author":"Louveau","year":"2015","journal-title":"Nature"},{"key":"R22-20230828","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nrd.2018.109","article-title":"Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing","volume":"17","author":"Boland","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"R23-20230828","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/ard.2006.057885","article-title":"Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system","volume":"66","author":"Tokunaga","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"R24-20230828","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12974-015-0423-4","article-title":"Neuropsychiatric systemic lupus erythematosus persists despite attenuation of systemic disease in MRL\/lpr mice","volume":"12","author":"Stock","year":"2015","journal-title":"J Neuroinflammation"},{"key":"R25-20230828","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/nm1101-1189","article-title":"A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus","volume":"7","author":"DeGiorgio","year":"2001","journal-title":"Nat Med"},{"key":"R26-20230828","doi-asserted-by":"crossref","first-page":"18569","DOI":"10.1073\/pnas.1006980107","article-title":"Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms","volume":"107","author":"Faust","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R27-20230828","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ebiom.2015.05.027","article-title":"Selective impairment of spatial cognition caused by autoantibodies to the N-methyl-D-aspartate receptor","volume":"2","author":"Chang","year":"2015","journal-title":"EBioMedicine"},{"key":"R28-20230828","doi-asserted-by":"crossref","first-page":"532","DOI":"10.12659\/MSM.912389","article-title":"Anti-N-methyl-D-aspartic acid receptor 2 (anti-NR2) antibody in neuropsychiatric lupus serum damages the blood-brain barrier and enters the brain","volume":"25","author":"Wang","year":"2019","journal-title":"Med Sci Monit"},{"key":"R29-20230828","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1136\/ard.2004.029280","article-title":"Autoantibodies to a NR2A peptide of the glutamate\/NMDA receptor in sera of patients with systemic lupus erythematosus","volume":"64","author":"Husebye","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"R30-20230828","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/art.21539","article-title":"Accuracy of anti\u2013ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis","volume":"54","author":"Karassa","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R31-20230828","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/art.1780390907","article-title":"Association of antiribosomal P protein antibodies with neuropsychiatric systemic lupus erythematosus","volume":"39","author":"Isshi","year":"1996","journal-title":"Arthritis Rheum"},{"key":"R32-20230828","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/art.39081","article-title":"Pathogenicity of lupus antiribosomal P antibodies: role of cross-reacting neuronal surface P antigen in glutamatergic transmission and plasticity in a mouse model","volume":"67","author":"Segovia-Miranda","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R34-20230828","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1084\/jem.20071285","article-title":"Antiribosomal-P autoantibodies from psychiatric lupus target a novel neuronal surface protein causing calcium influx and apoptosis","volume":"204","author":"Matus","year":"2007","journal-title":"J Exp Med"},{"key":"R35-20230828","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/art.38900","article-title":"Antiribosomal P protein autoantibodies from patients with neuropsychiatric lupus impair memory in mice","author":"Bravo-Zehnder","year":"2015","journal-title":"Arthritis RheumatolV 67"},{"key":"R36-20230828","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/art.22419","article-title":"Induction of autoimmune depression in mice by antiribosomal P antibodies via the limbic system","volume":"56","author":"Katzav","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R37-20230828","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1177\/0961203310375262","article-title":"Thrombotic microangiopathy and the antiphospholipid syndrome","volume":"19","author":"Johnsen","year":"2010","journal-title":"Lupus"},{"key":"R38-20230828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2018.06.010","article-title":"Subclinical atherosclerosis in asymptomatic carriers of persistent antiphospholipid antibodies positivity: a cross-sectional study","volume":"274","author":"Di Minno","year":"2019","journal-title":"Int J Cardiol"},{"key":"R39-20230828","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.neuron.2014.03.003","article-title":"Stepwise recruitment of transcellular and paracellular pathways underlies blood-brain barrier breakdown in stroke","volume":"82","author":"Knowland","year":"2014","journal-title":"Neuron"},{"key":"R40-20230828","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s11064-008-9902-7","article-title":"Effects of exogenous excitatory amino acid neurotransmitters on blood-brain barrier disruption in focal cerebral ischemia","volume":"34","author":"Chi","year":"2009","journal-title":"Neurochem Res"},{"key":"R41-20230828","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jneuroim.2014.04.003","article-title":"Antibody-specific behavioral effects: Intracerebroventricular injection of antiphospholipid antibodies induces hyperactive behavior while antiribosomal-P antibodies induces depression and smell deficits in mice","volume":"272","author":"Katzav","year":"2014","journal-title":"J Neuroimmunol"},{"key":"R42-20230828","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3389\/fimmu.2018.00698","article-title":"Microglia and beyond: innate immune cells as regulators of brain development and behavioral function","volume":"9","author":"Lenz","year":"2018","journal-title":"Front Immunol"},{"key":"R43-20230828","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12974-014-0171-x","article-title":"Estrogen receptor alpha deficiency protects against development of cognitive impairment in murine lupus","volume":"11","author":"Cunningham","year":"2014","journal-title":"J Neuroinflammation"},{"key":"R44-20230828","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.neuron.2014.02.040","article-title":"Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain","volume":"82","author":"Elmore","year":"2014","journal-title":"Neuron"},{"key":"R45-20230828","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.clim.2016.08.019","article-title":"CSF-1R inhibition attenuates renal and neuropsychiatric disease in murine lupus","volume":"185","author":"Chalmers","year":"2017","journal-title":"Clin Immunol"},{"key":"R46-20230828","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jneuroim.2017.07.010","article-title":"Microglia activation induced by serum of SLE patients","volume":"310","author":"Wang","year":"2017","journal-title":"J Neuroimmunol"},{"key":"R47-20230828","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1084\/jem.20180776","article-title":"Lupus antibodies induce behavioral changes mediated by microglia and blocked by ACE inhibitors","volume":"215","author":"Nestor","year":"2018","journal-title":"J Exp Med"},{"key":"R48-20230828","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.ijbiomac.2018.12.146","article-title":"TNF-\u03b1 regulates microglial activation via the NF-\u03baB signaling pathway in systemic lupus erythematosus with depression","volume":"125","author":"Kong","year":"2019","journal-title":"Int J Biol Macromol"},{"key":"R49-20230828","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.3389\/fimmu.2018.02189","article-title":"Neuropsychiatric systemic lupus erythematosus is dependent on sphingosine-1-phosphate signaling","volume":"9","author":"Mike","year":"2018","journal-title":"Front Immunol"},{"key":"R50-20230828","doi-asserted-by":"crossref","first-page":"5204","DOI":"10.4049\/jimmunol.1301637","article-title":"Phenotypic polarization of activated astrocytes: the critical role of lipocalin-2 in the classical inflammatory activation of astrocytes","volume":"191","author":"Jang","year":"2013","journal-title":"J Immunol"},{"key":"R51-20230828","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaut.2018.08.005","article-title":"Lipocalin-2 is a pathogenic determinant and biomarker of neuropsychiatric lupus","volume":"96","author":"Mike","year":"2018","journal-title":"J Autoimmun"},{"key":"R52-20230828","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fimmu.2015.00092","article-title":"Regulation of tissue responses: the TWEAK\/Fn14 pathway and other TNF\/TNFR superfamily members that activate non-canonical NF\u03baB signaling","volume":"6","author":"Burkly","year":"2015","journal-title":"Front Immunol"},{"key":"R53-20230828","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.3389\/fimmu.2017.01534","article-title":"Regulation of neuroinflammation: what role for the tumor necrosis factor-like weak inducer of apoptosis\/fn14 pathway?","volume":"8","author":"Boulamery","year":"2017","journal-title":"Front Immunol"},{"key":"R54-20230828","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jaut.2013.03.002","article-title":"Neuropsychiatric disease in murine lupus is dependent on the TWEAK\/Fn14 pathway","volume":"43","author":"Wen","year":"2013","journal-title":"J Autoimmun"},{"key":"R55-20230828","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jaut.2015.03.005","article-title":"TNF-like weak inducer of apoptosis promotes blood brain barrier disruption and increases neuronal cell death in MRL\/lpr mice","volume":"60","author":"Wen","year":"2015","journal-title":"J Autoimmun"},{"key":"R56-20230828","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.bbi.2015.12.017","article-title":"Intracerebroventricular administration of TNF-like weak inducer of apoptosis induces depression-like behavior and cognitive dysfunction in nonautoimmune mice","volume":"54","author":"Wen","year":"2016","journal-title":"Brain Behav Immun"},{"key":"R57-20230828","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13075-017-1500-0","article-title":"Highly selective inhibition of Bruton's tyrosine kinase attenuates skin and brain disease in murine lupus","volume":"20","author":"Chalmers","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"R58-20230828","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0140-6736(18)31363-1","article-title":"Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"392","author":"Wallace","year":"2018","journal-title":"Lancet"},{"key":"R59-20230828","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1056\/NEJMoa1901981","article-title":"Placebo-controlled trial of an oral BTK inhibitor in multiple sclerosis","volume":"380","author":"Montalban","year":"2019","journal-title":"N Engl J Med"},{"key":"R60-20230828","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jneuroim.2017.06.008","article-title":"Neuropsychiatric involvement in lupus is associated with the Nogo-a\/NgR1 pathway","volume":"311","author":"Lei","year":"2017","journal-title":"J Neuroimmunol"},{"key":"R61-20230828","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri3850","article-title":"Aicardi \u2013 Gouti\u00e8res syndrome and the type I interferonopathies","volume":"15","author":"Crow","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"R62-20230828","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/ng2091","article-title":"Mutations in the gene encoding the 3\u2032-5\u2032 DNA exonuclease TREX1 are associated with systemic lupus erythematosus","volume":"39","author":"Lee-Kirsch","year":"2007","journal-title":"Nat Genet"},{"key":"R63-20230828","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1136\/ard.2009.114157","article-title":"TREX1 gene variant in neuropsychiatric systemic lupus erythematosus","volume":"69","author":"de Vries","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R64-20230828","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1182\/blood-2007-05-089086","article-title":"Interferon-alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis","volume":"110","author":"Denny","year":"2007","journal-title":"Blood"},{"key":"R65-20230828","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1056\/NEJMc1316118","article-title":"Thrombotic microangiopathy associated with interferon beta","volume":"370","author":"Hunt","year":"2014","journal-title":"N Engl J Med"},{"key":"R66-20230828","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1136\/annrheumdis-2018-214379","article-title":"Combined genetic and transcriptome analysis of patients with SLE: distinct, targetable signatures for susceptibility and severity","volume":"78","author":"Panousis","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"R67-20230828","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1093\/brain\/aww031","article-title":"Glial and axonal changes in systemic lupus erythematosus measured with diffusion of intracellular metabolites","volume":"139","author":"Ercan","year":"2016","journal-title":"Brain"},{"key":"R68-20230828","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/0961203316657432","article-title":"Neuroimaging of translocator protein in patients with systemic lupus erythematosus: a pilot study using [11C]DPA-713 positron emission tomography","volume":"26","author":"Wang","year":"2017","journal-title":"Lupus"},{"key":"R69-20230828","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/annrheumdis-2017-212285","article-title":"Neuropsychiatric lupus or not? Cerebral hypoperfusion by perfusion-weighted MRI in normal-appearing white matter in primary neuropsychiatric lupus erythematosus","volume":"77","author":"Papadaki","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R70-20230828","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1002\/art.39653","article-title":"Changes in white matter microstructure suggest an inflammatory origin of neuropsychiatric systemic lupus erythematosus","volume":"68","author":"Magro-Checa","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"R71-20230828","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/0961203313511556","article-title":"In vivo evaluation of brain damage in the course of systemic lupus erythematosus using magnetic resonance spectroscopy, perfusion-weighted and diffusion-tensor imaging","volume":"23","author":"Zimny","year":"2014","journal-title":"Lupus"},{"key":"R72-20230828","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1002\/art.27458","article-title":"The histopathologic associates of neurometabolite abnormalities in fatal neuropsychiatric systemic lupus erythematosus","volume":"62","author":"Brooks","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R73-20230828","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1136\/annrheumdis-2018-214677","article-title":"Altered cognitive function in systemic lupus erythematosus and associations with inflammation and functional and structural brain changes","volume":"78","author":"Barraclough","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"R74-20230828","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1749-6632.2011.06076.x","article-title":"PET\/CT imaging in systemic lupus erythematosus","volume":"1228","author":"Curiel","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"R75-20230828","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3389\/fmed.2019.00052","article-title":"Editorial: lupus and the brain: advances in neuropsychiatric systemic lupus erythematosus","volume":"6","author":"Fanouriakis","year":"2019","journal-title":"Front Med"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000655","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T00:33:25Z","timestamp":1721608405000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":74,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000655","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11]]}}}